Scyliorhinin II
CAS No. 112748-19-3
Scyliorhinin II ( —— )
产品货号. M30549 CAS No. 112748-19-3
Scyliorhinin II, a cyclic Tachykinin peptide, is a potent NK3 receptor agonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1519 | 有现货 |
|
10MG | ¥2491 | 有现货 |
|
25MG | ¥4990 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
5MG | ¥1519 | 有现货 |
|
10MG | ¥2491 | 有现货 |
|
25MG | ¥4990 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Scyliorhinin II
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Scyliorhinin II, a cyclic Tachykinin peptide, is a potent NK3 receptor agonist.
-
产品描述Scyliorhinin II, a cyclic Tachykinin peptide, is a potent NK3 receptor agonist.(In Vitro):Scyliorhinin II is a neurokinin-3 selective tachykinin receptor, with a Ki of 2.5 nM for neurokinin-3 (NK-3) receptor in rat cerebral cortex. Scyliorhinin II has little effect on NK-1 and NK-2 receptors, with Ki (NK-1 receptor)/Ki (NK-3 receptor) and Ki (NK-2 receptor)/Ki (NK-3 receptor) of 176 and 200.(In Vivo):Scyliorhinin II produces potent, dose-related reciprocal hindlimb scratching about equipotently with an ED50 of 0.08 nmol via intracerebroventricularly (i.c.v.) administration in mice.
-
同义词——
-
通路GPCR/G Protein
-
靶点Neurokinin Receptor
-
受体Ki: 2.5 nM (Neurokinin-3 receptor)
-
研究领域——
-
适应症——
化学信息
-
CAS Number112748-19-3
-
分子量1851.1
-
分子式C77H119N21O26S3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Buck SH, et al. The dogfish peptides scyliorhinin I and scyliorhinin II bind with differential selectivity to mammalian tachykinin receptors. Eur J Pharmacol. 1987 Nov 24;144(1):109-11.
产品手册
关联产品
-
Maropitant
Maropitant is a selective neurokinin (NK1) receptor antagonist.
-
GR-64349
GR-64349 is a potent and selective tachykinin NK2 receptor agonist with EC50 of 3.7 nM.
-
NKP-608
A non-peptidic, specific, potent and orally active NK1 receptor antagonist with IC50 of 2.6 nM.